*.**.*

Source link : https://www.newshealth.biz/health-news/infliximab-biosimilars-uptake-in-us-reveals-ongoing-concerns/

TOPLINE: Uptake of infliximab biosimilars rose slowly across private insurance, Medicaid, and Medicare when two were available in the United States during 2016-2020 but increased significantly through 2022 after the third biosimilar became available in July 2020. However, prescriptions in Medicare still lagged behind those in private insurance and Medicaid. METHODOLOGY: Researchers analyzed electronic health […]

Author : News Health

Publish date : 2024-08-07 13:27:15

Copyright for syndicated content belongs to the linked Source.

........
........................................$$$$$$$$$$$$$$$$$$$$--------------------